Skip to content

A Study on the Efficacy Evaluation of Yi Sui Xing Shen Acupuncture Rehabilitation Treatmentn for Acute Stroke Patients with Cognitive Impairment

A Study on the Efficacy Evaluation of Yi Sui Xing Shen Acupuncture Rehabilitation Treatmentn for Acute Stroke Patients with Cognitive Impairment

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000246
Enrollment
Unknown
Registered
2025-02-13
Start date
2025-02-28
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-stroke cognitive impairment

Interventions

treatment group:"Yi Sui Xing Shen" Acupuncture Rehabilitation Treatment

Sponsors

Dongzhimen Hospital Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) One or more acute cerebrovascular disease (ischemic) events occurred within 3 to 14 days which can be clearly traced and cerebral infarction was diagnosed by CT or MRI; (2) Patients or family members subjectively reported cognitive decline after the stroke event with normal or mildly impaired daily living ability but the impaired daily living ability was not associated with motor/sensory symptoms caused by the stroke event. (3) Cognitive neuropsychological scale: MOCA17 points primary school >20 points middle school and above >24 points; (4) judged to be right-handed (EHI score > 40); (5) The age of onset is 18-80 years old gender and nationality are not limited; (6)NIHSS score < 20 points; (7) The subject gives informed consent and signs the informed consent voluntarily.

Exclusion criteria

Exclusion criteria: (1) Any known cognitive impairment including alcohol-induced cognitive impairment has been diagnosed before the onset of the stroke event; (2) Symptoms or manifestations that may affect the neuropsychological evaluation such as severe hearing speech or emotional disorders uncontrolled active mental illness and post-stroke physical disabilities that affect the psychological evaluation; (3) Patients with severe comorbidities such as severe cardiopulmonary dysfunction liver and kidney dysfunction and unstable vital signs; (4) Patients had been treated with cognitive enhancers and other anti-dementia agents including but not limited to cholinesterase inhibitors and non-competitive n-methyl-D-aspartate receptor antagonists within 1 month prior to the screening period; (5) Pregnant or lactating women.

Design outcomes

Primary

MeasureTime frame
Montreal Cognitive Assessment, MoCA;

Secondary

MeasureTime frame
Loewenstein occupational therapy cognitive assessment, LOTCA;rs-fMRI;task-fMRI;mini-mental state examination, MMSE;EEG;activity of daily living, ADL;event-related potential, ERP;Hamilton depression scale, HAMD;HamiltonAnxiety Scale, HAMA;Ischemic stroke syndrome factor diagnostic scale;DTI;Inflammatory serum biomarkers;HBV;HRV;3D-MRI;National Institutes of Health Stroke Scale, NIHSS;Serum biological indicators related to neural plasticity;

Countries

China

Contacts

Public ContactJingling Chang

Xiamen Hospital of TCM.

ear6979@163.com18611181701

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026